Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma

被引：17
|
作者：
Oki, Yasuhiro [1 ]
Copeland, Amanda [1 ]
Romaguera, Jorge [1 ]
Fayad, Luis [1 ]
Fanale, Michelle [1 ]
Faria, Silvana de Castro [2 ]
Medeiros, L. Jeffrey [3 ]
Ivy, Percy [4 ]
Younes, Anas [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Rockville, MD USA
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 05期
关键词：
PHASE-I TRIAL; CELL-CYCLE ARREST; ADVANCED CANCER; ALK EXPRESSION; KINASE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; COMPLEX; AKT;
D O I：
10.3109/10428194.2011.631236
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：990 / 992
页数：3
相关论文
共 50 条
  • [41] Heat shock protein-90: Independent predictor of rheumatoid arthritis-associated usual interstitial pneumonia
    Assal, Hebatallah H.
    Shalaby, Alaa
    Farrag, Samar H.
    Ali, Asmaa
    Ibrahim, Iman M.
    Elkaffas, Rasha H.
    Sabry, Irene M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2022, 71 (04): : 474 - 480
  • [42] PEI or GSH coated gold nanoparticles conjugated to cullin-5 DNA and heat shock protein 90 inhibitor, tanespimycin, for breast cancer therapy
    Talamantez-Lyburn, Sarah
    Ehrlich, Elana
    Devadas, Mary
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [43] Heat Shock Protein 90: Inhibitors in Clinical Trials
    Biamonte, Marco A.
    Van de Water, Ryan
    Arndt, Joseph W.
    Scannevin, Robert H.
    Perret, Daniel
    Lee, Wen-Cherng
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) : 3 - 17
  • [44] Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator
    B-W Xie
    D Park
    E R Van Beek
    V Blankevoort
    Y Orabi
    I Que
    E L Kaijzel
    A Chan
    P J Hogg
    C W G M Löwik
    Cell Death & Disease, 2013, 4 : e473 - e473
  • [45] Extracellular and Non-Chaperone Function of Heat Shock Protein-90α Is Required for Skin Wound Healing
    Bhatia, Ayesha
    O'Brien, Kathryn
    Guo, Jiacong
    Lincoln, Vadim
    Kajiwara, Chiaki
    Chen, Mei
    Woodley, David T.
    Udono, Heiichiro
    Li, Wei
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (02) : 423 - 433
  • [46] Secreted Heat Shock Protein-90α: A More Effective and Safer Target for Anti-Cancer Drugs?
    Cheng, Chieh-Fang
    Fan, Jianhua
    Zhao, Zhengwei
    Woodley, David T.
    Li, Wei
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2010, 5 (02) : 121 - 127
  • [47] Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models
    Hackl, Christina
    Mori, Akira
    Moser, Christian
    Lang, Sven A.
    Dayoub, Rania
    Weiss, Thomas S.
    Schlitt, Hans J.
    Geissler, Edward K.
    Hellerbrand, Claus
    Stoeltzing, Oliver
    SURGERY, 2010, 147 (05) : 704 - 712
  • [48] Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator
    Xie, B-W
    Park, D.
    Van Beek, E. R.
    Blankevoort, V.
    Orabi, Y.
    Que, I.
    Kaijzel, E. L.
    Chan, A.
    Hogg, P. J.
    Lowik, C. W. G. M.
    CELL DEATH & DISEASE, 2013, 4 : e473 - e473
  • [49] The role of secreted heat shock protein-90 (Hsp90) in wound healing - how could it shape future therapeutics?
    Guo, Jiacong
    Chang, Cheng
    Li, Wei
    EXPERT REVIEW OF PROTEOMICS, 2017, 14 (08) : 665 - 675
  • [50] Drug discovery and research of heat shock protein 90 (Hsp90) inhibitor
    Soga, Shiro
    Nakashima, Takayuki
    Ishii, Toshihiko
    Shiotsu, Yukimasa
    Akinaga, Shiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 26P - 26P
12345